Lemelson Capital's Fr. Emmanuel Lemelson Responds To Civil Complaint Filed Against Him Today by SEC Alleging Securities Law Violations Related To Trading Ligand Pharma, Says This Matter 'Has no merit...amounts to a gross abuse of prosecutorial discretion'